This HTML5 document contains 49 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
n9http://localhost/temp/predkladatel/
n15http://linked.opendata.cz/resource/domain/vavai/projekt/
n5http://linked.opendata.cz/resource/domain/vavai/riv/tvurce/
n11http://linked.opendata.cz/ontology/domain/vavai/
n17http://linked.opendata.cz/resource/domain/vavai/vysledek/RIV%2F00216208%3A11150%2F05%3A00003501%21RIV06-MSM-11150___/
shttp://schema.org/
n4http://linked.opendata.cz/ontology/domain/vavai/riv/
skoshttp://www.w3.org/2004/02/skos/core#
n2http://linked.opendata.cz/resource/domain/vavai/vysledek/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://linked.opendata.cz/ontology/domain/vavai/riv/klicoveSlovo/
n16http://linked.opendata.cz/ontology/domain/vavai/riv/duvernostUdaju/
xsdhhttp://www.w3.org/2001/XMLSchema#
n14http://linked.opendata.cz/ontology/domain/vavai/riv/jazykVysledku/
n10http://linked.opendata.cz/ontology/domain/vavai/riv/aktivita/
n18http://linked.opendata.cz/ontology/domain/vavai/riv/obor/
n8http://linked.opendata.cz/ontology/domain/vavai/riv/druhVysledku/
n13http://reference.data.gov.uk/id/gregorian-year/

Statements

Subject Item
n2:RIV%2F00216208%3A11150%2F05%3A00003501%21RIV06-MSM-11150___
rdf:type
skos:Concept n11:Vysledek
dcterms:description
41 patients with psoriasis were treated with 7,5 mg or 15 mg MTX administered once a week. The pharmacokinetic of MTX were evaluated at week 1 and 13, MTX in erythrocytes and the PASI-score were evaluated repeatedly. There was a strong correlation between MTX AUC at week 1 and PASI at week 13 (rho = -0,08, p 0,0001). Nemocní s těžkou psoriázou (N = 41) byly léčeni MTX v nízkých dávkách (7,5 nebo 15 mg) 1x týdně. Farmakokinetika MTX, jeho koncentrace v erytrocytech a klinický stav (skore PASI) byly hodnoceny opakovaně v průběhu prvních 13ti týdnů. Byla nalezena vysoce signifikantní korelace mezi AUCMTX v prvním týdnu a stavem onemocnění kůže ve třináctém týdnu (PASI) (rho = -0,08, p 0,0001) 41 patients with psoriasis were treated with 7,5 mg or 15 mg MTX administered once a week. The pharmacokinetic of MTX were evaluated at week 1 and 13, MTX in erythrocytes and the PASI-score were evaluated repeatedly. There was a strong correlation between MTX AUC at week 1 and PASI at week 13 (rho = -0,08, p 0,0001).
dcterms:title
Low-dose methotrexate pharmacokinetics and pharmacodynamics in the therapy of severe psoriasis Farmakokinetika a farmakodynamika nízkých dávek metotrexátu v léčbě těžké psoriázy Low-dose methotrexate pharmacokinetics and pharmacodynamics in the therapy of severe psoriasis
skos:prefLabel
Farmakokinetika a farmakodynamika nízkých dávek metotrexátu v léčbě těžké psoriázy Low-dose methotrexate pharmacokinetics and pharmacodynamics in the therapy of severe psoriasis Low-dose methotrexate pharmacokinetics and pharmacodynamics in the therapy of severe psoriasis
skos:notation
RIV/00216208:11150/05:00003501!RIV06-MSM-11150___
n4:strany
247;248
n4:aktivita
n10:P
n4:aktivity
P(1P04OCB15.10)
n4:cisloPeriodika
3
n4:dodaniDat
n13:2006
n4:domaciTvurceVysledku
n5:5929040 n5:5481546 n5:3405133 n5:1802054 n5:5448379
n4:druhVysledku
n8:J
n4:duvernostUdaju
n16:S
n4:entitaPredkladatele
n17:predkladatel
n4:idSjednocenehoVysledku
528476
n4:idVysledku
RIV/00216208:11150/05:00003501
n4:jazykVysledku
n14:eng
n4:klicovaSlova
methotrexate; psoriasis; pharmacokinetics
n4:klicoveSlovo
n12:methotrexate n12:pharmacokinetics n12:psoriasis
n4:kodStatuVydavatele
GB - Spojené království Velké Británie a Severního Irska
n4:kontrolniKodProRIV
[2F8860B0B75F]
n4:nazevZdroje
Basic and Clinical Pharmacology and Toxicology
n4:obor
n18:FR
n4:pocetDomacichTvurcuVysledku
5
n4:pocetTvurcuVysledku
5
n4:projekt
n15:1P04OCB15.10
n4:rokUplatneniVysledku
n13:2005
n4:svazekPeriodika
96
n4:tvurceVysledku
Vaněčková, Jaroslava Martínková, Jiřina Šimková, Marie Grim, Jiří Chládek, Jaroslav
s:issn
1742-7835
s:numberOfPages
2
n9:organizacniJednotka
11150